"Cathepsins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES.
Descriptor ID |
D002403
|
MeSH Number(s) |
D08.811.277.656.224
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cathepsins".
Below are MeSH descriptors whose meaning is more specific than "Cathepsins".
This graph shows the total number of publications written about "Cathepsins" by people in this website by year, and whether "Cathepsins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 3 | 0 | 3 |
2006 | 2 | 1 | 3 |
2008 | 2 | 2 | 4 |
2009 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2013 | 1 | 2 | 3 |
2014 | 1 | 0 | 1 |
2015 | 1 | 2 | 3 |
2016 | 0 | 1 | 1 |
2017 | 4 | 0 | 4 |
2018 | 2 | 1 | 3 |
2019 | 0 | 1 | 1 |
2020 | 1 | 4 | 5 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cathepsins" by people in Profiles.
-
Inhibition of Cysteine Proteases by 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea. Molecules. 2021 Aug 05; 26(16).
-
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics. Virol J. 2021 07 23; 18(1):154.
-
Environmentally-induced mdig contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism. Theranostics. 2021; 11(16):7970-7983.
-
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol. 2021 07; 6(7):899-909.
-
Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Protein Sci. 2021 06; 30(6):1131-1143.
-
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. PLoS Pathog. 2021 02; 17(2):e1009225.
-
Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro. Biochem Biophys Res Commun. 2021 03 26; 546:97-102.
-
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020 12 01; 116(14):2207-2215.
-
Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses. JAMA. 2020 11 03; 324(17):1712.
-
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection. 2020 Oct; 48(5):665-669.